Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Neurocrine Biosciences EBITDA Margin 2010-2024 | NBIX

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Neurocrine Biosciences (NBIX) over the last 10 years. The current EBITDA margin for Neurocrine Biosciences as of December 31, 2024 is .
  
Neurocrine Biosciences EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-12-31 $2.36B $0.57B 24.25%
2024-09-30 $2.24B $0.59B 26.14%
2024-06-30 $2.12B $0.54B 25.63%
2024-03-31 $1.98B $0.46B 23.41%
2023-12-31 $1.89B $0.26B 13.51%
2023-09-30 $1.78B $0.23B 12.72%
2023-06-30 $1.67B $0.17B 10.28%
2023-03-31 $1.60B $0.15B 9.39%
2022-12-31 $1.49B $0.27B 18.00%
2022-09-30 $1.39B $0.14B 9.79%
2022-06-30 $1.30B $0.10B 7.40%
2022-03-31 $1.21B $0.11B 8.86%
2021-12-31 $1.13B $0.14B 12.17%
2021-09-30 $1.07B $0.24B 22.34%
2021-06-30 $1.03B $0.15B 14.52%
2021-03-31 $1.05B $0.16B 15.68%
2020-12-31 $1.05B $0.19B 18.36%
2020-09-30 $1.04B $0.17B 16.22%
2020-06-30 $1.01B $0.30B 30.15%
2020-03-31 $0.89B $0.26B 29.31%
2019-12-31 $0.79B $0.10B 12.56%
2019-09-30 $0.68B $0.07B 10.22%
2019-06-30 $0.61B $0.03B 5.45%
2019-03-31 $0.52B $0.00B -0.77%
2018-12-31 $0.45B $0.06B 13.08%
2018-09-30 $0.42B $0.05B 12.29%
2018-06-30 $0.32B $-0.01B -3.09%
2018-03-31 $0.23B $-0.07B -28.76%
2013-12-31 $0.00B $-0.05B -1150.00%
2013-09-30 $0.03B $-0.03B -104.00%
2013-06-30 $0.03B $-0.02B -54.55%
2013-03-31 $0.04B $-0.01B -13.95%
2012-12-31 $0.05B $0.01B 9.43%
2012-09-30 $0.04B $0.00B -7.14%
2012-06-30 $0.08B $0.03B 41.33%
2012-03-31 $0.08B $0.03B 43.42%
2011-12-31 $0.08B $0.04B 47.44%
2011-09-30 $0.08B $0.04B 45.68%
2011-06-30 $0.05B $0.01B 16.98%
2011-03-31 $0.05B $0.00B 4.35%
2010-12-31 $0.03B $-0.01B -32.35%
2010-09-30 $0.02B $-0.02B -95.24%
2010-06-30 $0.01B $-0.03B -400.00%
2010-03-31 $0.00B $-0.04B -1050.00%
2009-12-31 $0.00B $-0.05B -1250.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.630B $2.355B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $94.222B 35.35
Zoetis (ZTS) United States $71.986B 26.86
Daiichi Sankyo, - (DSNKY) Japan $47.632B 24.23
Takeda Pharmaceutical (TAK) Japan $45.406B 9.03
Sandoz Group AG (SDZNY) Switzerland $19.756B 0.00
Summit Therapeutics (SMMT) United States $18.307B 0.00
Merck (MKKGY) Germany $17.693B 14.64
United Therapeutics (UTHR) United States $13.893B 12.29
Shionogi (SGIOY) Japan $13.832B 13.86
IPSEN (IPSEY) France $9.997B 0.00
Orion OYJ (ORINY) Finland $8.541B 23.10
Corcept Therapeutics (CORT) United States $7.569B 61.53
Stevanato Group S.p.A (STVN) Italy $6.808B 41.63
Madrigal Pharmaceuticals (MDGL) United States $6.651B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.212B 0.00
Grifols, S.A (GRFS) Spain $5.019B 0.00
Soleno Therapeutics (SLNO) United States $3.843B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.062B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.776B 9.73
Hypermarcas (HYPMY) Brazil $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.312B 12.64
NewAmsterdam Pharma (NAMS) Netherlands $2.116B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.765B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.650B 0.00
Guardian Pharmacy Services (GRDN) United States $1.613B 0.00
Indivior (INDV) United States $1.514B 6.42
Evotec AG (EVO) Germany $1.388B 0.00
ARS Pharmaceuticals (SPRY) United States $1.325B 168.62
Dyne Therapeutics (DYN) United States $1.283B 0.00
Ocular Therapeutix (OCUL) United States $1.187B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.108B 45.06
Enliven Therapeutics (ELVN) United States $0.914B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.907B 0.00
Collegium Pharmaceutical (COLL) United States $0.876B 4.73
Ardelyx (ARDX) United States $0.871B 0.00
Harrow (HROW) United States $0.865B 0.00
Xeris Biopharma Holdings (XERS) United States $0.807B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Akebia Therapeutics (AKBA) United States $0.686B 0.00
AleAnna (ANNA) United States $0.679B 0.00
Organogenesis (ORGO) United States $0.677B 0.00
Xencor (XNCR) United States $0.625B 0.00
KalVista Pharmaceuticals (KALV) United States $0.606B 0.00
Bioventus (BVS) United States $0.557B 14.17
Savara (SVRA) United States $0.556B 0.00
USANA Health Sciences (USNA) United States $0.543B 11.81
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Relay Therapeutics (RLAY) United States $0.514B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.495B 0.00
Elite Pharmaceuticals (ELTP) United States $0.466B 0.00
Altimmune (ALT) United States $0.447B 0.00
Zevra Therapeutics (ZVRA) United States $0.426B 0.00
CytoDyn (CYDY) United States $0.417B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.408B 0.00
Tourmaline Bio (TRML) United States $0.404B 0.00
Verve Therapeutics (VERV) United States $0.399B 0.00
Siga Technologies (SIGA) United States $0.389B 8.12
Oruka Therapeutics (ORKA) United States $0.365B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.13
Heron Therapeutics (HRTX) United States $0.331B 0.00
Aquestive Therapeutics (AQST) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.27
Avita Medical (RCEL) United States $0.247B 0.00
Wellgistics Health (WGRX) United States $0.216B 0.00
ProKidney (PROK) United States $0.205B 0.00
OmniAb (OABI) United States $0.192B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Esperion Therapeutics (ESPR) United States $0.177B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Nanobiotix S.A (NBTX) France $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.156B 0.00
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Profound Medical (PROF) Canada $0.150B 0.00
Korro Bio (KRRO) United States $0.145B 0.00
Larimar Therapeutics (LRMR) United States $0.143B 0.00
Aclaris Therapeutics (ACRS) United States $0.142B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Lyell Immunopharma (LYEL) United States $0.126B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.113B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.113B 0.00
Lexeo Therapeutics (LXEO) United States $0.100B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Achieve Life Sciences (ACHV) Canada $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Cassava Sciences (SAVA) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.082B 13.45
Corbus Pharmaceuticals Holdings (CRBP) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.063B 50.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Vivani Medical (VANI) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Prelude Therapeutics (PRLD) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Surrozen (SRZN) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
BioVie (BIVI) United States $0.023B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 7.52
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Plus Therapeutics (PSTV) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00